BB Biotech AG announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was CHF 728.166 million compared to CHF 5.777 million a year ago. Net income was CHF 677.431 million compared to net loss of CHF 471.343 million a year ago. Basic earnings per share was CHF 12.23 compared to basic loss per share of CHF 8.51 a year ago.